Individual variation of drop-out: zoomed (6 subjects), full FOV (5 subjects), and low resolution EPI (5 subjects). by Cheryl A. Olman (176715)

Proliferative Olig2 cell numbers increase within 2d after TBI and remain elevated to at least 3 months. by Krista A. Dent (709531)

E14.5 differential expression analyses. by Andrew B. Harvey (21587431)

Dissipative Dynamics and Uncertainty Measures of a Charged Oscillator in the Presence of the Aharonov-Bohm Effect by J. P. G. Nascimento (10478491)

“…For the Caldirola-Kanai model, we observe that the flux parameter v decreases the energy dissipation in a quantum dot for a certain range of t.…”

Detection of apoptotic cells with Annexin V assay. by Yihui Chen (446576)

Methotrexate susceptibility of <i>L</i>. <i>major</i> Friedlin mutants derived from a Mut-seq screen. by Sophia Bigot (16469992)

A meta-regression analysis of undernutrition by year of publication. by Nagwa Farag Elmighrabi (15194969)

The LCS stream is absent in E16.5 <i>Emx1</i>-cKO mice. by Sathish Venkataramanappa (10331993)

Effect of anti-miR-146a LNA or miR-146a mimic upon IL-1β-induced release of inflammatory molecules. by Anand Iyer (135705)

“…<p>(<b>A</b>) Cytokine release 24 hours after exposure to IL-1β in U373 cells transfected with LNA-antimiR-146a (50 nM) or miR-146a mimic (miR-146a mimic, 50 nM). …”

Decomposition analysis of AYAs with liver cancer. by Mengjia Zhu (15469202)

“…Regarding SDI regions, we found that the ASIR of AYAs with CRC increased in all five Social Demographic Index (SDI) regions. …”

In vitro angiogenesis assay using Matrigel to characterize the antiangiogenic effect mediated by treatment scheme with topotecan and melphalan. by Ursula Winter (3145773)

“…Experiments were performed in triplicate wells and five areas from each well were analyzed. The bar graph illustrates the significant decrease in the percentage of branch points after topotecan or melphalan used in a conventional or metronomic fashion compared to PBS-treated (control) cells or between treatment schedules. …”

Expression of autophagy related proteins in canine cells treated with the autophagy inhibitor spautin-1, doxorubicin, or a combination, with spautin-1 applied pre-chemotherapy. by Courtney R. Schott (5904980)

Mean number of high-risk/high-return choices across trials along with standard deviations. by Yuji Takano (252785)

Image_5_Genetic Variation in CCL5 Signaling Genes and Triple Negative Breast Cancer: Susceptibility and Prognosis Implications.JPEG by Jingxuan Shan (4711089)

“…We found a highly significant association between the CCND1 rs614367-TT genotype (OR = 5.14; P = 0.004) and TNBC risk, and identified a significant association between the rs614367-T allele and decreased PFS in TNBC. …”

Table_5_Genetic Variation in CCL5 Signaling Genes and Triple Negative Breast Cancer: Susceptibility and Prognosis Implications.DOCX by Jingxuan Shan (4711089)

“…We found a highly significant association between the CCND1 rs614367-TT genotype (OR = 5.14; P = 0.004) and TNBC risk, and identified a significant association between the rs614367-T allele and decreased PFS in TNBC. …”

H12 values in sweeps of varying softness. by Nandita R. Garud (694498)

“…H12 values rapidly decline as the softness of a sweep increases and as the ending partial frequency of the adaptive allele decreases. In (C) and (D), <i>s</i> was varied while keeping <i>PF</i> constant at 0.5 for sweeps from <i>de novo</i> mutations and SGV, respectively. …”

Model performance comparison. by Shayla Naznin (13014015)

“…</p><p>Conclusions</p><p>From 1994 to 2018, under-5 mortality in Bangladesh decreased by 76.72%. …”

THS exposure in conjunction with antioxidant treatment for 2.5 and 5 months alleviates metabolic syndrome in a dose-dependent manner. by Neema Adhami (516427)

“…Antioxidant+THS treated mice had reduced fasting blood glucose levels <b>(B)</b>, decreased fasting insulin levels <b>(C)</b>, greatly restored protein levels in insulin signaling proteins IR, PI3K and AKT <b>(D-F)</b>, and lower HOMA-IR index (fasting blood glucose X Fasting insulin/22.5) <b>(G)</b>. …”

Fig 6 - by Matthew C. Kochem (18476069)

“…Plasma glucose, insulin, and glucagon were measured before, during, and after OGTTs up to 120 minutes post-prandially. We also assessed individual participants’ sweet taste responses to sucralose and their sensitivities to lactisole sweetness inhibition. …”

Fig 2 - by Matthew C. Kochem (18476069)

“…Plasma glucose, insulin, and glucagon were measured before, during, and after OGTTs up to 120 minutes post-prandially. We also assessed individual participants’ sweet taste responses to sucralose and their sensitivities to lactisole sweetness inhibition. …”